Search
AN2 Therapeutics Inc
ANTXAdd to Watchlist
3.550USD
-0.090-2.47%
Close 10-23 16:00（ET）
133.98MMarket Cap
LossP/E TTM
AN2 Therapeutics Inc (ANTX) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to AN2 Therapeutics Inc in the past month.
Strong Buy
2 Strong Buy
0 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
9.000USD+166.27%
ANTX Analyst Recommendation Trends
In the current month, ANTX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANTX average Analyst price target in the last month is 9.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
1
1
1
1
1
Financial Forecasting
Based on analysts' estimates, ANTX EPS is projected to reach -0.200 in FY2026Q3, following reported EPS of -0.183 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.24
-0.23
-0.27
-0.20
-0.23
Actual
-0.29
-0.29
-0.18
--
--
Surprise
-19.55%
-28.01%
+32.27%
--
--
FAQs
What is AN2 Therapeutics Inc's price target?
Analysts forecast that AN2 Therapeutics Inc's price target is USD 1.50, with the highest forecast at USD 2.00 and the lowest forecast at USD 1.00.
How have AN2 Therapeutics IncANTX's recent earnings per share performed?
The market expectation was USD -0.18, while AN2 Therapeutics IncANTX's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for AN2 Therapeutics Inc?
Based on the ratings of AN2 Therapeutics Inc's stock from 2 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.